We build impactful digital pathology diagnostics to directly improve patient outcomes.

Diagnostics

Tip arrowTip arrowTip arrow

Challenges

What if we could help pathologists and oncologists deliver precision medicine to their patients?

Treatment burden

Treatments for cancer can be toxic, invasive and expensive and may not always be necessary or effective

Disease heterogeneity

Cancer is a highly heterogeneous disease, even cancer of one tissue will have many subtypes that each respond to treatments differently

Anatomic pathology is underutilized

Digital pathology slides hold vast amounts of hidden insights and unlike genomic data, they are routinely generated in the clinical workflow

Treatment burden

Treatments for cancer can be toxic, invasive and expensive and may not always be necessary or effective

Disease heterogeneity

Cancer is a highly heterogeneous disease, even cancer of one tissue will have many subtypes that each respond to treatments differently

Anatomic pathology is underutilized

Digital pathology slides hold vast amounts of hidden insights and unlike genomic data, they are routinely generated in the clinical workflow

Products

Owkin’s solutions

Owkin delivers AI diagnostics that integrate seamlessly into the digital pathology workflow to support accurate diagnosis at a fraction of the time and cost of existing tests. Our solutions help pre-screen for biomarkers, and predict outcomes— giving healthcare providers a fuller picture of a patient’s disease. This means more patients can benefit from targeted therapies, making precision medicine more accessible to more patients at an earlier stage of their disease.

Owkin’s digital pathology based diagnostics can also be developed, either in house or through partnership, into Companion Diagnostics to support the clinical development and market access of novel drugs.